Seroatlas · Human Serome Atlas

TPM1

Tropomyosin alpha-1 chain

Also known as: C15orf13, CMH3, TPM1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P09493
Gene
TPM1
Ensembl
ENSG00000140416
Chromosome
15
Canonical length
284 aa
Protein class
Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Actin filaments,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]

Canonical amino-acid sequenceUniProt

284 residues, UniProt reviewed canonical sequence.

>P09493|TPM1
     1  MDAIKKKMQM LKLDKENALD RAEQAEADKK AAEDRSKQLE DELVSLQKKL KGTEDELDKY
    61  SEALKDAQEK LELAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA
   121  DESERGMKVI ESRAQKDEEK MEIQEIQLKE AKHIAEDADR KYEEVARKLV IIESDLERAE
   181  ERAELSEGKC AELEEELKTV TNNLKSLEAQ AEKYSQKEDR YEEEIKVLSD KLKEAETRAE
   241  FAERSVTKLE KSIDDLEDEL YAQKLKYKAI SEELDHALND MTSI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TPM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.49
Highest tissue expression
11,881 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 11,881 nTPM
  • heart muscle: 10,511 nTPM
  • tongue: 4,840 nTPM
  • colon: 2,621 nTPM
  • blood vessel: 1,843 nTPM
  • smooth muscle: 1,638 nTPM

Single-cell type

  • smooth muscle cells: 5,778 nCPM
  • extravillous trophoblasts: 4,741 nCPM
  • breast myoepithelial cells: 3,061 nCPM
  • hepatic stellate cells: 2,634 nCPM
  • vascular smooth muscle cells: 2,223 nCPM
  • thymic myoid cells: 2,042 nCPM

Immune cell

  • basophil: 49 nTPM
  • intermediate monocyte: 19 nTPM
  • total PBMC: 16 nTPM
  • non-classical monocyte: 14 nTPM
  • myeloid DC: 14 nTPM
  • neutrophil: 11 nTPM

Brain region

  • choroid plexus: 90 nTPM
  • cerebral cortex: 76 nTPM
  • hippocampal formation: 76 nTPM
  • basal ganglia: 76 nTPM
  • cerebellum: 73 nTPM
  • thalamus: 70 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TPM1.

Disease | AllUniProt

Conditions TPM1 is implicated in, by any mechanism.

Disease | GeneticClinVar

54 pathogenic / likely-pathogenic of 1,072 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

ReferencesPubMed · IEDB

Publications for TPM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.78
gnomAD pLI
0
gnomAD missense Z
2.87
DepMap mean gene effect
0.06
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TPM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TPM1 as an antibody target. Whether an autoantibody or antibody against TPM1 could matter depends on whether native TPM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TPM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TPM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TPM1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...